Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03201573
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
CPI | 6-CARBOXYPIPERIDINE | A,B,C,D,F,Q | 1EFR | 0.72 | |
CPI | 6-CARBOXYPIPERIDINE | B | 1EOL | 0.72 | |
CPI | 6-CARBOXYPIPERIDINE | B | 1EOJ | 0.72 | |
CPI | 6-CARBOXYPIPERIDINE | A,B,C,D,E,F, G,H,I,J,K,L | 1W3M | 0.72 | |
CPI | 6-CARBOXYPIPERIDINE | A,B | 2ITK | 0.72 | |
CPI | 6-CARBOXYPIPERIDINE | A,B | 2Q5A | 0.72 | |
CCL | N~6~-[(CYCLOPENTYLOXY)CARBONYL]- D-LYSINE | A | 2Q7G | 0.81 | |
193 | (2S)-4-(BETA-ALANYLAMINO)-2-AMINOBUTANOIC ACID | A | 1XY5 | 0.7 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2B4D | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD9 | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVR | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVS | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVQ | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OT7 | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2B5G | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A | 2GIV | 0.81 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNY | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A | 1JSP | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B,I,L | 2V5W | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,D | 3D4B | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OQ6 | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2R0Y | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A | 3CZ7 | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A | 1JM4 | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H4H | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2J6V | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2R10 | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1YC5 | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OX0 | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2G | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,D | 2H4F | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A | 2OU2 | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1S5P | 0.81 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNW | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A | 3D35 | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD2 | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A | 2ZFN | 0.81 | |
ALY | N(6)-ACETYLLYSINE | C,D | 2C1J | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2QQG | 0.81 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNX | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1MA3 | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2H | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A | 2I2Z | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD7 | 0.81 | |
ALY | N(6)-ACETYLLYSINE | P | 1E6I | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1SZC | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D,I,J, K,L | 3EWF | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2D | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1Q1A | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1SZD | 0.81 | |
ALY | N(6)-ACETYLLYSINE | Q,R | 2E3K | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A | 2OZU | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2QQF | 0.81 | |
ALY | N(6)-ACETYLLYSINE | A,B,C | 2R0V | 0.81 | |
CYK | N-hexanoyl-L-homocysteine | A | 3DHC | 0.73 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 2BJS | 0.72 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1QJE | 0.72 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BK0 | 0.72 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BLZ | 0.72 | |
5FP | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID | A,B | 1XE6 | 0.72 | |
BCV | D-(L-A-AMINOADIPOYL)-L-CYSTEINYL- D-CYCLOPROPYLGLYCINE | A | 2IVJ | 0.71 | |
0AZ | (4R)-4-hydroxy-L-proline | A | 1GQ0 | 0.72 | |
ACC | N-[N-[2-AMINO-6-OXO-HEXANOIC ACID- 6-YL]CYSTEINYL]-S-METHYLCYSTEINE | A | 1QIQ | 0.71 | |
CLH | 2-AMINO-6-[2-(2-OXO-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.83 | |
ATI | N-(3-AMINO-2-HYDROXY-5-METHYLHEXANOYL)VALYLVALYLASPARTIC ACID | A | 1Y0Y | 0.81 | |
AN0 | N-ACETYL-L-NORVALINE | C,D,E,X,Y,Z | 2G7M | 0.74 | |
AN0 | N-ACETYL-L-NORVALINE | A | 1ZQ8 | 0.74 | |
AAG | N-ALPHA-L-ACETYL-ARGININE | A | 1DRY | 0.7 | |
5FE | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID METHYL ESTER | A,B | 1XE5 | 0.72 | |
CLG | 2-AMINO-6-[2-(2-AMINOOXY-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.85 | |
0AG | N-(ethoxycarbonyl)-L-leucine | I,J | 1PSA | 0.71 | |
AOR | N~2~-ACETYL-L-ORNITHINE | A | 1ZQ6 | 0.75 | |
AR9 | (2R,4S)-N-butyl-4-[(2S,5S,7R)-2,7- dimethyl-3,15-dioxo-1,4-diazacyclopentadecan- 5-yl]-4-hydroxy-2-methylbutanamide | A,B,C | 3DV1 | 0.7 | |
C6L | N-hexanoyl-L-homoserine | A | 3DHA | 0.85 | |
C6L | N-hexanoyl-L-homoserine | A | 3DHB | 0.85 |